Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

CNS Drugs

Issue 11/2008

Content (6 Articles)

Leading Article

Preventing Alzheimer’s Disease

Mary Sano, Hillel Grossman, Kathleen Van Dyk

Review Article

Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders

David A. Smelson, Lisa Dixon, Thomas Craig, Stephen Remolina, Steven L. Batki, Noosha Niv, Richard Owen

Review Article

Designing Clinical Trials to Assess Antiepileptic Drugs as Monotherapy

Emilio Perucca

Review Article

Sleep Disturbances in Patients with Schizophrenia

Stefan Cohrs

Original Research Article

Differences in Medication Adherence and Healthcare Resource Utilization Patterns

David V. Sheehan, Matthew S. Keene, Michael Eaddy, Stan Krulewicz, John E. Kraus, David J. Carpenter

Adis Spotlight

Spotlight on Eszopiclone in Insomnia

Philip I. Hair, Paul L. McCormack, Monique P. Curran

Oct 08
Issue: 10/2008
Dec 08
Issue: 12/2008

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more